Neisseria gonorrhoeae: Difference between revisions
From IDWiki
Neisseria gonorrhoeae
(Initial page creation) |
(Added anorectal gonorrhea) |
||
| Line 1: | Line 1: | ||
| + | == Clinical Presentation == |
||
| + | |||
| + | === Anorectal gonorrhea === |
||
| + | |||
| + | * Often asymptomatic |
||
| + | * Can cause anorectal pain, discharge, and pruritis |
||
| + | * Anal intercourse not required, especially in women |
||
| + | |||
| + | == Diagnosis == |
||
| + | |||
| + | * Resistance |
||
| + | ** MDR gonorrhea: resistance to one of azithromycin or a cephalosporin |
||
| + | ** XDR if resistance to both azithromycin and a cephalosporin |
||
{{DISPLAYTITLE:''Neisseria gonorrhoeae''}} |
{{DISPLAYTITLE:''Neisseria gonorrhoeae''}} |
||
Revision as of 11:20, 27 August 2019
Clinical Presentation
Anorectal gonorrhea
- Often asymptomatic
- Can cause anorectal pain, discharge, and pruritis
- Anal intercourse not required, especially in women
Diagnosis
- Resistance
- MDR gonorrhea: resistance to one of azithromycin or a cephalosporin
- XDR if resistance to both azithromycin and a cephalosporin
References
- ^ I Martin, P Sawatzky, V Allen, B Lefebvre, LMN Hoang, P Naidu, J Minion, P Van Caeseele, D Haldane, RR Gad, G Zahariadis, A Corriveau, G German, K Tomas, MR Mulvey. Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016. Canada Communicable Disease Report. 2019;45(2/3):45-53. doi:10.14745/ccdr.v45i23a01.
